Smoking Cessation Clinical Trial
Official title:
A Prospective, Placebo-controlled, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of the Use of Deep Transcranial Magnetic Stimulation (dTMS) on Smoking Cessation.
The purpose of this study is to evaluate the efficacy and safety of dTMS used as a tool for the smoking cessation; therefore, the subjects will be randomized to be treated on the active group or to receive placebo stimulation.
Smoking is the leading cause of preventable deaths in the world. Tobacco use causes more than
5 million deaths per year worldwide.
Among interventions methods that have been found to be effective, the medications are the
most promising, using drugs such as Varenicline and Bupropion. Nicotine replacement therapy
(NRT) shows results in combination to these drugs.
Alternative approaches to smoking cessation such as acupuncture, hypnosis, smokeless tobacco,
electronic cigarettes are not legitimated smoking cessation tools; given that scientific
studies showed no difference between these methods and placebo, or yet no rigorous
peer-reviewed studies have been conducted.
On the neuromodulation field, Repetitive Transcranial Magnetic Stimulation (rTMS) appears as
a new possibility to treat this serious condition.
The rTMS is a non-invasive method of stimulating cortical neurons. Repetitive TMS has been
tested as a treatment of various neuropsychiatric disorders associated with cortical
excitability disfunctions.
Several lines of evidence suggest that rTMS over the prefrontal cortex (PFC) can affect
processes involved in nicotine addiction. First, animal studies demonstrated that rTMS to the
frontal regions of rats enhanced release of dopamine in the hippocampus and NAc . Moreover,
high-frequency rTMS of the human prefrontal cortex (PFC) has been shown to induce dopamine
release in the caudate nucleus. Hence, it has been suggested that high-frequency rTMS may be
useful in disorders associated with subcortical dopamine dysfunction, such as addiction.
Several human studies have begun to evaluate the effects of rTMS protocols applied to the PFC
on drug craving and consumption in nicotine. Johann and colleagues reported decreased levels
of tobacco craving after single rTMS session over the left dorsolateral prefrontal cortex
(DLPFC). In addition, a single session of rTMS over the right DLPFC can reduce cocaine
craving. Eichhammer and colleagues in a cross-over, double-blind, placebo-controlled study
demonstrated a reduction in cigarette consumption (measured 6 hours following the treatment)
but craving levels remained unchanged after two rTMS sessions over the left DLPFC. Amiaz and
collegues found that 10 days of high-frequency rTMS over the DLPFC reduced cigarette
consumption and nicotine dependence. In addition, the rTMS blocked craving induced by smoking
cues. However, the effect tended to dissipate after the 10 daily sessions and the reduction
in cigarette consumption was not significant 6 months after treatment termination. Moreover,
only 10% among those who responded to the treatment had totally quit smoking. Li et al
treated subjects with real high-frequency rTMS or sham TMS over the DLPFC in two visits with
1 week between visits. The participants received cue exposure before and after rTMS.
Stimulation of the left DLFPC with real rTMS reduced craving significantly from baseline.
When compared with neutral cue craving, the effect of real TMS on cue craving was
significantly greater than the effect of sham TMS. Rudction in subjective craving induced by
TMS correlated positively with higher Fagerström Test for Nicotine Dependence score and more
cigarettes smoked per day. These four studies demonstrate that high-frequency rTMS of the
DLPFC can attenuate nicotine consumption and craving. However, the significance and duration
of these effects are limited and further investigation is required to identify the
appropriate stimulation parameters and targets needed to enhance the effectiveness of such
treatment.
One possible reason for these partial effects on nicotine consumption might be the
superficial magnetic stimulation induced by the figure-8 coil, which does not reach into the
deep layers of the cortex. It is known that nicotine addiction involves various areas of the
brain reward system. Most of them are deeper than the superficial layers of the cortex, like
the anterior cingulated, orbitofrontal cortex, nucleus accumbens, and amygdala.
Another area of interest which was not stimulated using the superficial rTMS is the insula. A
recent study explored the role of insula damage in addiction. In a retrospective design,
assessing changes in cigarette smoking after brain damage, results revealed that smokers with
brain damage involving the insula were significantly more likely to undergo a disruption of
smoking addiction than smokers with brain damage not involving the insula. This finding is
consistent with the crucial role of the insula in cravings for food, cocaine and cigarettes,
as reported by neuroimaging studies, and with the role of the insula in processes related to
decision-making. Therefore stimulating the insula and the deeper layers of the lateral PFC
could be substantially more effective in treating nicotine addiction.
Deep Transcranial Magnetic Stimulation (dTMS) is a new form of rTMS which allows direct
stimulation of deeper neuronal pathways than standard rTMS using the Brainsway's new H-coils.
In this study we will apply the dTMS using the H-ADD, which is designed to reach deeper brain
areas related to the control of motivation, reward and pleasure, specifically, fibers
connecting the DLPFC and the insula.
Given these theoretical, animal and preliminary human data, we hypothesized that a course of
deep high-frequency, using a specific coil for deep stimulation (H-ADD) over the right and
left lateral PFC and insula, may reduce impulsivity, nicotine dependence and craving for
cigarettes in response to smoking-related cues.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Adherence to Anti- Retroviral Therapy (ART) Among People Living With Human Immunodeficiency Virus (HIV)
|
Phase 4 | |
Completed |
NCT04617444 -
The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function
|
N/A | |
Completed |
NCT02796391 -
Facilitating Smoking Cessation With Reduced Nicotine Cigarettes
|
Phase 2 | |
Completed |
NCT03397511 -
Incorporating Financial Incentives to Increase Smoking Cessation Among Asian Americans Residing in New York City
|
N/A | |
Not yet recruiting |
NCT05188287 -
A Culturally Tailored Smartphone Application for African American Smokers
|
N/A | |
Recruiting |
NCT05264428 -
The Effect of Honey on Lessening the Withdrawal Symptoms
|
N/A | |
Completed |
NCT04133064 -
Assessment of the Pivot Breath Sensor: Single-Arm Cohort Study
|
N/A | |
Completed |
NCT03187730 -
Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants
|
Phase 4 | |
Completed |
NCT03474783 -
To Explore the Factors Affecting the Effectiveness of Smoking Cessation
|
N/A | |
Completed |
NCT04635358 -
Feasibility Study of Smoking Cessation for the Staff of a Hospital Center
|
N/A | |
Terminated |
NCT03670264 -
BE Smokefree: Behavioral Economics Incentives to Engage Adolescents in Smoking Cessation
|
N/A | |
Completed |
NCT02905656 -
Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit
|
N/A | |
Completed |
NCT02997657 -
Positive Psychotherapy for Smoking Cessation Enhanced With Text Messaging: A Randomized Controlled Trial
|
N/A | |
Completed |
NCT03206619 -
A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
|
||
Completed |
NCT02562521 -
A Smoking Cessation Intervention for Yale Dining Employees
|
Phase 4 | |
Completed |
NCT02239770 -
Pharmacokinetics of Nicotine Film in Smokers
|
N/A | |
Recruiting |
NCT02422914 -
Benefits of Tobacco Free Cigarette
|
N/A | |
Enrolling by invitation |
NCT02218944 -
Smoking Response Inhibition Training
|
N/A | |
Completed |
NCT03002883 -
STAND Community College Tobacco Cessation Trial
|
N/A |